Provided by Tiger Trade Technology Pte. Ltd.

Envoy Medical Inc.

0.6578
+0.00020.03%
Post-market: 0.65780.0002+0.03%16:00 EDT
Volume:34.81K
Turnover:23.09K
Market Cap:50.91M
PE:-0.87
High:0.6705
Open:0.6600
Low:0.6520
Close:0.6576
52wk High:1.02
52wk Low:0.3625
Shares:77.39M
Float Shares:43.22M
Volume Ratio:0.44
T/O Rate:0.08%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.7600
EPS(LYR):-1.2300
ROE:--
ROA:-86.53%
PB:13.78
PE(LYR):-0.53

Loading ...

Envoy Medical - Enters Dismissal Agreement with Atlas Merchant Capital Regarding Delaware Litigation, on Oct 6 - SEC Filing

THOMSON REUTERS
·
Oct 07

Envoy Medical - All Atlas Claims Dismissed with Prejudice; no Further Litigation Proceedings - SEC Filing

THOMSON REUTERS
·
Oct 07

Envoy Medical Says Atlas SPAC Fund Drops Delaware Chancery Lawsuit over Share Redemptions

Reuters
·
Oct 07

Envoy Medical Initiated at Buy by Lake Street

Dow Jones
·
Oct 07

Lake Street Initiates Coverage on Envoy Medical With Buy Rating, $2.50 Price Target

MT Newswires Live
·
Oct 06

Envoy Medical Wins New Canadian, Hong Kong Patents, Lifts Global Total to 97

Reuters
·
Sep 22

Fusemachines Names David R. Wells Consulting CFO

Reuters
·
Sep 05

Envoy Medical Announces Special Shareholder Meeting

Reuters
·
Sep 01

Envoy Medical Appoints Robert Potashnick Chief Accounting Officer, VP Finance

Reuters
·
Aug 28

Envoy Medical Price Target Cut to $2.00/Share from $2.50 by HC Wainwright & Co.

Dow Jones
·
Aug 21

Envoy Medical Announces Special Shareholder Meeting

Reuters
·
Aug 20

Envoy Medical’s Limited Disclosures Put Spotlight on 10-K Risk Factors for Investors

TIPRANKS
·
Aug 11

Envoy Medical: Expects to Submit Four Modules, Final Module of Pma Application Targeted for Submission in Q2 2027 - SEC Filing

THOMSON REUTERS
·
Aug 11

Envoy Medical: Q2 Net Loss Attributable to Common Stockholders was $0.07 Per Basic and Diluted Share

THOMSON REUTERS
·
Aug 11

Envoy Medical Q2 EPS $(0.07) Beats $(0.08) Estimate, Sales $51.000K Miss $80.000K Estimate

Benzinga Earnings
·
Aug 10

Envoy Medical Q2 FY26 Net Loss Attributable to Common Stockholders Widens to $7.27 Million; Revenue Falls 34.62% to $51,000

Reuters
·
Aug 10

Envoy Medical Initiated at Buy by LUCID Capital Markets

Dow Jones
·
Jul 27

Envoy Medical Inc Expected to Post a Loss of 9 Cents a Share - Earnings Preview

Reuters
·
Jul 27

Envoy Medical initiated with a Buy at Lucid Capital

TIPRANKS
·
Jul 27

Envoy Medical Announces Release of Press Statement

Reuters
·
Jul 21